NEWS

NEWS

The Second Sino-Korea Symposium on Tuberculosis successfully held online

2023-11-01

1ST December 2023, Beijing30th November 2023, hosted by Beijing Chest Hospital, the World Health Organization Collaborating Center on Tuberculosis Research and Training (WHOCC), Clinical Center on Tuberculosis, China Center of Disease Prevention and Control (CCTB), Innovation Alliance (IATB) with Shangdong Lukang Orion Quratis Bio Tech providing technical assistance, the second Sino-Korea sympos...
The Second National Tuberculosis Innovation Forum Successfully Held in Haikou, Hainan Province

2023-04-24

24th April, 2023, HaikouInnovation leads the future is the theme of this year’s forum, which has been successfully held from 20-22nd April, Haikou city, Hainan province. The second national TB innovation forum is collaboration between Beijing Chest Hospital, Clinical Center on Tuberculosis, China Center of Disease Prevention and Control and Innovation Alliance (IATB) with technical assistance a...
Beijing Chest Hospital Leads a National Multi-Center Randomized Clinical Trials on a Short Course All Oral Regimen for MDR/RR-TB (PROSPECT Study)

2022-06-13

13th June, 2022, Beijing Multi drug resistant tuberculosis (MDR-TB) still represents a serious threat to global public health. Treatment success rate of traditional long course regimen (≥18 month) for this disease lingers below 60%. In order to improve the efficacy of MDR-TB treatment in China, led by Dr. Mengqiu Gao, head physician of No. 2 tuberculosis ward of Beijing Chest Hospital, a random...
The Successful Organization of The Second Tuberculosis R&D Collaboration International Forum

2022-05-01

1st May, 2022, Beijing From 27th-29th April 2022, the Second TB R&D Collaboration International Forum has been successfully staged online. While the forum has been hosted by the Innovation Alliance on Tuberculosis Diagnosis and Treatment (IATB), Beijing Chest Hospital and Clinical Center on TB, China CDC, it is generously endorsed by the Bill & Melinda Gates Foundation (BMGF) both as our...
First < 1 2 3 4 5 6 7 8 9 > Last